About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Cancer: bladder
Cancer: brain
Cancer: breast
Cancer: gastroenterological
Cancer: gynaecological
Cancer: haematological
Cancer: kidney
Cancer: lung
Cancer: other
Cancer: pancreas
Cancer: prostate
Cancer: skin
Leukaemia
Lymphoma
Radiotherapy
243 library items
in Cancer: gynaecological
Filter results by:
Date Published
2012 (2)
2011 (37)
2010 (40)
2009 (49)
2008 (39)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Oncology (
remove
)
,
Cancer: gynaecological (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 243
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
Bevacizumab (AvastinĀ®) approved in the EU for ovarian cancer
Source:
Personal communication (Roche)
,
Date published:
23/01/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: gynaecological
|
European Agency for the Evaluation of Medicinal Products (EMEA)
|
Licence extension
NeLM
Area:
News
PharmaTimes report (free registration required)
2.
RCTs of bevacizumab in ovarian cancer report improved PFS
Source:
N Engl J Med
,
Date published:
05/01/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: gynaecological
NeLM
Area:
News
Abstract (ICON7)
Abstract (GOG study)
3.
Horizon scanning: Phase II study of IV aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer
Source:
Lancet Oncology
,
Date published:
22/12/2011
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: gynaecological
|
New drugs
NeLM
Area:
News
Abstract
Link to comment- full text may be restricted to subscribers
4.
NHS Evidence expert commentary: The contraceptive pill and ovarian cancer risk
Source:
NHS Evidence
,
Date published:
16/12/2011
Category:
7.3.1 Combined hormonal contraceptives
|
Cancer: gynaecological
NeLM
Area:
News
Link to registration page for Eyes on Evidence
Link to back copies of Eyes on Evidence
5.
NHS Choices assessment of press reports about ovarian cancer risk from IVF
Source:
NHS Choices
,
Date published:
28/10/2011
Category:
6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens
|
Adverse Drug Reactions
|
Cancer: gynaecological
|
Obstetrics &Gynaecology
NeLM
Area:
News
Link to assessment
Study abstract
6.
Epidermal growth factor receptor blockers for the treatment of ovarian cancer
Source:
Cochrane Library
,
Date published:
22/10/2011
Category:
8: Malignant disease and immunosuppression
|
Cancer: gynaecological
|
Drug reviews
NeLM
Area:
Evidence
>
Drug Class Focused Reviews
Link to Abstract
7.
Adjuvant chemotherapy for endometrial cancer after hysterectomy
Source:
Cochrane Library
,
Date published:
19/10/2011
Category:
Cancer: gynaecological
|
Drug reviews
NeLM
Area:
Evidence
>
Disease Focused Reviews
Abstract
8.
Observational study finds BRCA2 carriers respond better to ovarian cancer chemotherapy
Source:
JAMA
,
Date published:
13/10/2011
Category:
8.1 Cytotoxic drugs
|
Cancer: gynaecological
NeLM
Area:
News
Link (abstrac)
Editorial
9.
Angiogenesis inhibitors for the treatment of ovarian cancer
Source:
Cochrane Library
,
Date published:
26/09/2011
Category:
Cancer: gynaecological
|
Drug reviews
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link to Abstract
10.
European CHMP adopts positive opinion on application for license extension of bevacizumab (AvastinĀ®)
Source:
EMA
,
Date published:
23/09/2011
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: gynaecological
|
Cancer: other
|
Licence extension
NeLM
Area:
News
Positive opinion
Results 1 - 10 of 243
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next